APOTHEEK VERSE
ActiveThe computed 12-month bankruptcy probability of APOTHEEK VERSE is 1.9% (moderate). The 2025 annual accounts show negative equity (€-64k) and a net result of €-6k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 10252 sector peers (fiscal year 2025). The company has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
27
/ 100
Weak
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability16▲+16
Solvency0=
Growth32=
Track record100
Bankruptcy probability, 12 months
1.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.7 against 0.62 in 2024; short-term debt: 137.9% and cash: 13.7% of total assets), and equity is negative.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-65.5%
Return on assets
-5.8%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €-64k
neutral · A punctual record breaks
This company filed 3 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-08-2026, 13 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filingsDeviation from the deadline
2025
13 d late
2024
21 d early
2023
30 d early
2022
60 d early
2021
8 d late
2020
33 d early
2019
42 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€-64k▼ 9.7%
2024 · €-59k
2018: €-510
2019: €15k
2020: €912
2021: €-23k
2022: €-12k
2023: €-26k
2024: €-59k
2018 → 2025
Total assets
€98k▼ 9.1%
2024 · €108k
2018: €197k
2019: €203k
2020: €181k
2021: €145k
2022: €139k
2023: €135k
2024: €108k
2018 → 2025
Net result
€-6k▲ 82.8%
2024 · €-33k
2018: €-716
2019: €16k
2020: €-14k
2021: €-23k
2022: €11k
2023: €-14k
2024: €-33k
2018 → 2025
Working capital
€-41k▲ 34.0%
2024 · €-62k
2018: €-26k
2019: €-7k
2020: €-18k
2021: €-36k
2022: €-23k
2023: €-33k
2024: €-62k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€-23k-€-12k▲ 46.8%€-26k▼ 114%€-59k▼ 129%€-64k▼ 9.7%
Operating result€-14k-€6k€-11k€-33k▼ 194%€-1k▲ 95.7%
Net result€-23k-€11k€-14k€-33k▼ 142%€-6k▲ 82.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €1k in 2025 against €33k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €98k
Fixed assets
€4k▼ 46.7%
Current assets
€95k▼ 6.5%
Key figures and ratios
EBITDA
€2k▲
2024 · €-29k
Cash flow
€-2k▲
2024 · €-30k
Solvency
-65.5%▼
2024 · -54.2%
Current ratio
0.70▲
2024 · 0.62
Quick ratio
0.16▲
2024 · 0.11
Debt / equity
-2.53▲
2024 · -2.84
ROA
-5.8%▲
2024 · -30.5%
Interest coverage
0.55▲
2024 · -12.40
Debt
€163k▼
2024 · €167k
Debt ≤ 1 year
€136k▼
2024 · €163k
Debt > 1 year
€20k
Income taxes
€256▲
2024 · €230
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€108k€98k▼
Fixed assets21/28€7k€4k▼
Tangible fixed assets22/27€7k€4k▼
Land and buildings22€7k€3k▼
Plant, machinery and equipment23-€233
Current assets29/58€101k€95k▼
Stocks and contracts in progress3€84k€73k▼
Stocks30/36€84k€73k▼
Amounts receivable within one year40/41€12k€6k▼
Trade receivables40€12k€5k▼
Other amounts receivable41-€934
Cash at bank and in hand54/58€4k€14k▲
Deferred charges and accrued income490/1€2k€2k▲
Equity and liabilities
Total equity and liabilities10/49€108k€98k▼
Equity10/15€-59k€-64k▼
Contributions10/11€25k€25k=
Reserves13€1k€1k=
Distributable reserves133€1k€1k=
Profit (loss) carried forward14€-85k€-91k▼
Amounts payable17/49€167k€163k▼
Amounts payable after more than one year17-€20k
Financial debts170/4-€20k
Amounts payable within one year42/48€163k€136k▼
Trade debts44€113k€52k▼
Suppliers440/4€113k€52k▼
Taxes, remuneration and social security45€755€258▼
Taxes450/3€755€258▼
Other amounts payable47/48€50k€83k▲
Accrued charges and deferred income492/3€4k€7k▲
Income statement
Code20242025
Non-recurring operating income76A€844-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€4k▲
Other operating charges640/8€9k€4k▼
Gross operating margin9900€-20k€6k▲
Operating profit (loss)9901€-33k€-1k▲
Financial income75/76B€2k€3▼
Recurring financial income75€0€0▲
Non-recurring financial income76B€2k€2▼
Financial charges65/66B€2k€4k▲
Recurring financial charges65€2k€4k▲
Profit (loss) for the period before taxes9903€-33k€-5k▲
Income taxes67/77€230€256▲
Profit (loss) for the period9904€-33k€-6k▲
Profit (loss) for the period to be appropriated9905€-33k€-6k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-85k€-91k▼
Profit (loss) brought forward from the previous period14P€-52k€-85k▼
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
13-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 13 days late
2025
10-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Weakest financial yearnet €-33k
Net result drops to €-33k, the lowest in the series; recovery starts the following year.
01-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
01-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Back to profitnet €11k
Net result €11k after 2 loss-making years.
08-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 8 days late
2021
28-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
19-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Back to profitnet €16k
Net result €16k after one loss-making year.
24-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
16-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
17-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 17 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Marnixlaan 161000 BrusselGround area
1,359 m²
Building footprint
1,263 m²
Volume, LiDAR
37,591 m³
Parcel 21805E0551/00F000, Brussels · tallest building 37.3 m, ±11 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK VERSE
since 20082.167.005.140
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21805E0551/00F000 | Brussels | 1,359 m² | 1 · 1,263 m² | 37.3 m · 11 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteBrussel2.167.005.140
Similar companies · same sector, comparable size
MDN Pharmaceutics
BE 1032.175.218
Brussel · Eq €873
BELESSENTIAL
BE 1001.518.565
Sprimont · Eq €868
AVERROES PHARMA
BE 0738.813.960
Sint-Jans-Molenbeek · Eq €999
APOTHEEK VERSCHAEVE-BARTELEN
BE 0451.903.303
Beveren-Kruibeke-Zwijndrecht · Eq €1k
LISANNE MOONS
BE 0737.837.230
Zonhoven · Eq €1k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,863. 81 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded05-12-2007
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.